COMMUNIQUÉS West-GlobeNewswire

SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros
20/05/2026
BRUXELLES, 20 mai 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, ci-après « SERB », et Hansa Biopharma AB, ci-après « Hansa » (Nasdaq Stockholm : HNSA) annoncent la conclusion d’un accord portant sur l’acquisition, par [...]
Shiny Smile Veneers Claims Evaluated (2026 Consumer Report Update) Critical Complaints Investigated
20/05/2026
Dr. Dean's Dentist-Designed Custom Snap-On Veneers: At-Home Impressions, FDA-Approved Biocompatible Resin, 3-Year Warranty, and 60-Day Money-Back Guarantee Richardson, TX , May 19, 2026 (GLOBE NEWSWIRE) -- Results may [...]
Java Tide Critical Assessment: The Gelatin Ice Trick Before Bed Using the Java Tide Formula Recipe
20/05/2026
Java Tide Scam or Legit, Complaints, Side Effects, and Supplement Ingredients: Chicory Root Inulin, Resistant Starch, Akkermansia muciniphila, and Gut Support Largo, FL, May 19, 2026 (GLOBE NEWSWIRE) -- These statements [...]
SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide
20/05/2026
Chicory Root Inulin, Resistant Starch, and Akkermansia Muciniphila Probiotic Blend for Gut Microbiome and Metabolic Support Explained Largo, FL, May 19, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated [...]
Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants
19/05/2026
MALVERN, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
19/05/2026
PONTE VEDRA, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, [...]
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
19/05/2026
SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling [...]
Suja Life to Report First Quarter 2026 Financial Results on June 9, 2026
19/05/2026
OCEANSIDE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life” or the “Company”), a leading better-for-you beverage company and maker of Suja Organic , Vive Organic , and Slice Soda , [...]
Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity
19/05/2026
Phase IV head-to-head, double-blind trial comparing safety and efficacy met its primary and secondary endpoints The DIRECTION trial results show the safety profile for Dysport ® (abobotulinumtoxinA) was non-inferior to [...]
Iridex Reports First Quarter 2026 Financial Results
19/05/2026
2026 Guidance Affirmed MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and [...]
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
19/05/2026
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 46 th Annual [...]
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
19/05/2026
ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in [...]
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
19/05/2026
IMPAVIDO ® is the first and only FDA-approved oral therapy for visceral, cutaneous, and mucosal leishmaniasis caused by specific Leishmania species Leishmaniasis is a rare but potentially life-threatening parasitic [...]
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19/05/2026
BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) (“Aura” or the “Company”), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ [...]
Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
19/05/2026
KUALA LUMPUR, Malaysia, May 19, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and [...]
Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
19/05/2026
Company is Entering a Pivotal Phase to Demonstrate Value of its Unique Oral Vaccine Platform Emphasizes Need for the Right Board Leadership at Critical Strategic Juncture Encourages Shareholders to Visit Vote.Vaxart.com [...]
Olema Oncology to Participate in Upcoming Investor Conferences
19/05/2026
SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease
19/05/2026
WILMETTE, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet [...]
Ozari Health Launches Nationwide Telehealth Platform for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month
19/05/2026
LegitScript-verified platform connects patients with licensed providers for GLP-1 weight loss treatment, with transparent pricing, multiple pharmacy options, and no long-term contracts. New York, NY, May 19, 2026 (GLOBE [...]

Pages